Product Name：(1,3,5-Triazine-2,4,6-triyl)tris(benzene-4,1-diyl))triboronic Acid
Synonymous：BTA；2,4,6-tris(4′-dihydroxyborylphenyl)-1,3,5-triazine
CAS：910231-21-9
Synonymous：BTA；2,4,6-tris(4′-dihydroxyborylphenyl)-1,3,5-triazine
CAS：910231-21-9
Basic Info
| M.F. | C21H18B3N3O6 | M.W. | 440.817 | ||
| Appearance | |||||
Properties
1) 910231-21-9 soluble in DCM, DMF, DMSO, etc.
2) Sealed at 2-8 ℃
2) Sealed at 2-8 ℃
Appications
1) It could be used as monomer linker for COF synthesis：BTA-COF-1/2/3/4
Characterization
Reference
1) Cui, Y.; Wang, S.; J. Org. Chem. 2006, 71(17), 6485-6496, DOI:10.1021/jo060841 ; Diboron and Triboron Compounds Based on Linear and Star-Shaped Conjugated Ligands with 8-Hydroxyquinolate Functionality: Impact of Intermolecular Interaction and Boron Coordination on Luminescence +
2) Gontarczyk, K.; Bury, W.; Serwatowski, J.; Wieciński, P.; Woźniak, K.; Durka, K.; Luliński, S. ACS Appl. Mater. Interfaces 2017, 9, 31129– 31141, DOI: 10.1021/acsami.7b09061 ; Hybrid Triazine-Boron Two-Dimensional Covalent Organic Frameworks: Synthesis, Characterization, and DFT Approach to Layer Interaction Energies
3) Sarkar, K.; Dastidar, P.; Langmuir 2018, 34(2), 685-692, DOI: 10.1021/acs.langmuir.7b03326 ; Supramolecular Hydrogel Derived from a C3-Symmetric Boronic Acid Derivative for Stimuli-Responsive Release of Insulin and Doxorubicin
